Recent advances in the synthesis, structural diversification, and biological evaluation of sulfamethoxazole derivatives.

Authors

Ahmed H M Elwahy, Mohamed R Shaaban, Ismail A Abdelhamid

Published in

RSC advances. Oct 21, 2026. Epub Oct 21, 2026.

Abstract

Sulfamethoxazole is a clinically important sulfonamide antibiotic that remains a valuable pharmacophore in medicinal chemistry due to its established antibacterial activity and structural versatility. However, the emergence of antimicrobial resistance and limitations related to solubility, pharmacokinetics, and safety have encouraged extensive structural modification of the sulfamethoxazole scaffold. This review summarizes recent advances in the synthesis, structural diversification, and biological evaluation of sulfamethoxazole derivatives, with emphasis on developments reported during the last five years. Major synthetic approaches discussed include conventional sulfonamide-bond formation, greener synthetic protocols, metal complexation, Schiff base formation, nucleophilic substitution, amidation, cyanoacetylation, chloroacetylation, diazotization, heterocyclic annulation, and hybridization with other pharmacologically active scaffolds. Attention is given to how modification of the aromatic amino group, sulfonamide moiety, and isoxazole ring influences physicochemical properties and biological performance. The review also highlights sulfamethoxazole-based metal complexes, heterocyclic hybrids, prodrug-like derivatives, and nanocarrier-based systems as promising strategies to enhance antimicrobial potency and broaden biological applications, including anticancer, antioxidant, anti-inflammatory, enzyme-inhibitory, and antibiofilm activities. Overall, this review provides an integrated overview of the relationship between synthetic design, structural features, and biological activity, offering useful guidance for the future development of sulfamethoxazole-based therapeutic candidates.

PMID:
42909359
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.